Bhatia RT, Marwaha S, Malhotra A, et al. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020. 27: 1242–1251.
3.
GuzikTJMohiddinSADimarcoA, et al.
COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. Epub ahead of print 30 April 2020. DOI: 10.1093/cvr/cvaa106
4.
ShiSQinMCaiY, et al.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. Epub ahead of print 11 May 2020. DOI: 10.1093/eurheartj/ehaa408
ScharhagJMeyerT.Return to play after acute infectious disease in football players. J Sports Sci2014;
32: 1237–1242.
7.
PhelanDKimJHChungEH. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) Infection. JAMA Cardiol. Epub ahead of print 13 May 2020. DOI: 10.1001/jamacardio.2020.2136
HuiDSWongKTKoFW, et al.
The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest2005;
128: 2247–2261.
10.
NaksukNLazarSPeeraphatditTB.Cardiac safety of off-label COVID-19 drug therapy: A review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care2020; 9: 215–221.
NiebauerJBörjessonMCarreF, et al.
Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2019;
26: 1549–1555.